BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 9158255)

  • 41. Clinical applications of dendritic cell vaccines.
    Morse MA; Lyerly HK
    Curr Opin Mol Ther; 2000 Feb; 2(1):20-8. PubMed ID: 11249649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon therapy for ocular disease.
    Mackensen F; Max R; Becker MD
    Curr Opin Ophthalmol; 2006 Dec; 17(6):567-73. PubMed ID: 17065927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer vaccines: will we ever learn?
    Johnson RS; Walker AI; Ward SJ
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):67-74. PubMed ID: 19105708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferons as anticancer agents.
    Brodsky I; Hubbell HR
    Am Fam Physician; 1984 Jun; 29(6):246-8. PubMed ID: 6203394
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effects of interferon on various malignancies].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of interferons in the treatment of malignant neoplasms.
    Murren JR; Buzaid AC
    Yale J Biol Med; 1989; 62(3):271-90. PubMed ID: 2479178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interferons. New additions and indications for use.
    Stadler R; Ruszczak Z
    Dermatol Clin; 1993 Jan; 11(1):187-99. PubMed ID: 7679614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cytokines and cancer: update in 1998].
    NĂ©grier S
    Bull Cancer; 1999 Jan; 86(1):37-9. PubMed ID: 10029702
    [No Abstract]   [Full Text] [Related]  

  • 49. Biologic effects of interferons: relevance to multiple sclerosis.
    Rudick RA; Ransohoff RM
    Mult Scler; 1995; 1 Suppl 1():S12-6. PubMed ID: 9345391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon: anticancer agent having multifarious activity.
    Yabrov AA
    Prog Clin Cancer; 1982; 8():99-145. PubMed ID: 6185970
    [No Abstract]   [Full Text] [Related]  

  • 51. [Interferons, interleukin-2 and tumor necrosis factor. New approaches to cancer therapy].
    Oettgen HF
    Arzneimittelforschung; 1987 Feb; 37(2A):251-5. PubMed ID: 2436634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Interferon therapy in urology].
    Kriegmair M; Hofstetter A
    Urologe A; 1989 Mar; 28(2):116-21. PubMed ID: 2470188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma.
    Schmidt-Wolf IG; Finke S; Trojaneck B; Denkena A; Lefterova P; Schwella N; Heuft HG; Prange G; Korte M; Takeya M; Dorbic T; Neubauer A; Wittig B; Huhn D
    Br J Cancer; 1999 Nov; 81(6):1009-16. PubMed ID: 10576658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ASCO 2007: plenary top 5.
    Oncology (Williston Park); 2007 Jun; 21(7):896. PubMed ID: 17722746
    [No Abstract]   [Full Text] [Related]  

  • 55. [Interferons, a class of cytokines with a large therapeutic activity range].
    Billard C
    Bull Cancer; 1993 Sep; 80(9):741-56. PubMed ID: 7515733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunology in clinical practice. XII. Indications for T-Cell-mediated immunotherapy of cancer].
    Beun GD
    Ned Tijdschr Geneeskd; 1998 Feb; 142(8):392-6. PubMed ID: 9562772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.
    Pfeffer LM; Dinarello CA; Herberman RB; Williams BR; Borden EC; Bordens R; Walter MR; Nagabhushan TL; Trotta PP; Pestka S
    Cancer Res; 1998 Jun; 58(12):2489-99. PubMed ID: 9635566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical use of interferon].
    Lauta VM
    Clin Ter; 1996; 147(7-8):345-51. PubMed ID: 9118615
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
    Lee DS; White DE; Hurst R; Rosenberg SA; Yang JC
    Cancer J Sci Am; 1998; 4(2):86-93. PubMed ID: 9532410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medical treatment of brain metastases from solid tumours.
    Cappuzzo F; Mazzoni F; Maestri A; Di Stefano A; Calandri C; Crino L
    Forum (Genova); 2000; 10(2):137-48. PubMed ID: 10875975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.